4 European Projects Found
Searched on 125080 European Projects
FINISHED
NEURAL TRANSPLANTATION IN THE TREATMENT OF PATIENTS WITH PARKINSON’S DISEASE (TRANSEURO)
Start date: Jan 1, 2010, End date: Jun 30, 2016,
There are currently no cures for Parkinson's disease (PD) but one of the most effective reparative therapies in patients to date has been with allotransplants of dopamine (DA) neuroblasts obtained from fetal ventral mesencephalic (VM) tissue. However, this cell transplantation approach has given inconsistent results, with some patients doing extremely well and coming off anti-PD medication for yea ...
Read Project
15
Partners Participants
FINISHED
Phase II clinical trial of PDGF-BB for the neurological regeneration and recovery in Parkinson´s disease (NRT)
Start date: Jan 1, 2012, End date: Dec 31, 2015,
"The goal of this project is to perform a European phase II clinical trial to demonstrate that PDGF-BB acts as a unique regenerative therapy for Parkinson’s Disease (PD), aimed at reversing the course of the disease, by promotion of endogenous brain repair mechanisms. Current pharmacological therapies for PD carry side-effects and become less effective as the disease progresses. This causes immen ...
Read Project
10
Partners Participants
FINISHED
Regenerative medicine in Europe: emerging needs and challenges in a global context (REMEDiE)
Start date: May 1, 2008, End date: Apr 30, 2011,
The globalization of regenerative medicine is gathering pace yet has not been examined with respect to its medium and long term implications for European regulators, the corporate sector or patients located within different member states. Over the coming years it is hypothesised that the global pace of change in this field will be extensive and this needs to be both tracked and assessed for health ...
Read Project
7
Partners Participants
FINISHED
Biobanking and Biomolecular Resources Research Infrastructure (BBMRI)
Start date: Feb 1, 2008, End date: Jan 31, 2011,
...ses sustainability due to the lack of long-term funding. BBMRI will comprise: • biobanks of different formats (collections of blood, DNA, tissue, etc., together with medical, environmental, life-style and follow-up data), • biomolecular resources (antibody and affinity binder collections, ORF clone collections, siRNA libraries, proteins, cellular resources etc.), • enabling technologies and high-t ...
Read Project
